## Communicated by Alastair Brown Locus-specific databases (LSDBs) play an essential role in clinical care and research. They differ from traditional genetic databases in that they propose to place the mutations of ''anonymized'' patients directly on the World Wide Web. The proliferation of ethical
Hepatitis C databases, principles and utility to researchers
✍ Scribed by Carla Kuiken; Masashi Mizokami; Gilbert Deleage; Karina Yusim; Francois Penin; Tadasu Shin-I; Céline Charavay; Ning Tao; Daniel Crisan; Delphine Grando; Anita Dalwani; Christophe Geourjon; Ashish Agrawal; Christophe Combet
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 677 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
✦ Synopsis
Part of the effort to develop hepatitis C-specific drugs a nd vaccines is the study of genetic variability of allpublicly available HCV sequences. Three HCV databases are currently available to aid this effort and to provide additional insight into the basic biology, immunology, and evolution of the virus. The Japanese HCV database (http://s2as02.genes.nig.ac.jp) gives access to a genomic mapping of sequences as well as their phylogenetic relationships. The European HCV database (http://euhcvdb.ibcp.fr) offers access to a computer-annotated set of sequences and molecular models of HCV proteins and focuses on protein sequence, structure and function analysis. The HCV database at the Los Alamos National Laboratory in the United States (http://hcv.lanl.gov) provides access to a manually annotated sequence database and a database of immunological epitopes which contains concise descriptions of experimental results. In this paper, we briefly describe each of these databases and their associated websites and tools, and give some examples of their use in furthering HCV research.
📜 SIMILAR VOLUMES
that for gibbon ape leukemia virus. Proc Natl Acad Sci U S A strategies requires the practitioner to evaluate care-1994;91:78-82. fully all relevant data before instituting therapy. In-7. Van Zeijl M, Johan SV, Closs E, Cunningham J, Eddy R, Shows appropriate treatment with interferon alfa may exa-T
To assess possible role of testing for IgM-specific antibody in the diagnosis and monitoring of patients with hepatitis C, we tested sera from 14 patients with acute and 97 patients with chronic non-A, non-B hepatitis for IgG and IgM antibody to hepatitis C virus. IgG antibody to hepatitis C virus w